The effect of a protein kinase C inhibitor, H-7, on human neutrophil oxidative burst and degranulation

J Leukoc Biol. 1987 May;41(5):441-6. doi: 10.1002/jlb.41.5.441.

Abstract

The role of C-kinase in the activation of human polymorphonuclear leukocytes has been examined using H-7, a recently described C-kinase inhibitor. We found that H-7 will inhibit PMN superoxide anion release in response to the tumor promotor phorbol myristate acetate and the calcium ionophore A23187. In contrast, no inhibition by H-7 was seen for PMN superoxide release stimulated by the chemotactic peptide FMLP. H-7 did not inhibit PMN NADPH oxidase activity or PMN degranulation by any stimulant, but it reversed a phorbol ester-induced inhibition of granule release by FMLP. The results show that H-7 differentially affects the PMN functional events of secretion and superoxide release and suggests that an H-7 inhibitable C-kinase is not involved in chemotactic peptide induced activation of PMN and may not regulate stimulus induced PMN degranulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Calcium-Binding Proteins / pharmacology
  • Cells, Cultured
  • Humans
  • Isoquinolines / pharmacology*
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Neutrophils / drug effects*
  • Neutrophils / metabolism
  • Oxidation-Reduction
  • Piperazines / pharmacology*
  • Protein Kinase C / antagonists & inhibitors*
  • Superoxides / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Calcium-Binding Proteins
  • Isoquinolines
  • Piperazines
  • calciphorin
  • Superoxides
  • N-Formylmethionine Leucyl-Phenylalanine
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Protein Kinase C
  • Tetradecanoylphorbol Acetate